tacrine has been researched along with Atherosclerotic Parkinsonism in 5 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| ") proved capable of reducing jaw tremors in tacrine model of Parkinson's disease tremor." | 3.74 | Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. ( Borsini, F; Carminati, P; Frau, L; Morelli, M; Schintu, N; Simola, N; Tronci, E, 2007) |
| "Tacrine-treated rats showed a slight increase in the average initiation time for fast responses (i." | 1.30 | Motor dysfunction produced by tacrine administration in rats. ( Aberman, J; Carriero, DL; Gianutsos, G; Mayorga, AJ; Outslay, G; Salamone, JD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tronci, E | 1 |
| Simola, N | 1 |
| Borsini, F | 1 |
| Schintu, N | 1 |
| Frau, L | 1 |
| Carminati, P | 1 |
| Morelli, M | 1 |
| McSwain, ML | 1 |
| Forman, LM | 1 |
| Maany, I | 1 |
| Carriero, DL | 1 |
| Outslay, G | 1 |
| Mayorga, AJ | 1 |
| Aberman, J | 1 |
| Gianutsos, G | 1 |
| Salamone, JD | 1 |
| Cabeza-Alvarez, CI | 1 |
| González-Rubio, M | 1 |
| García-Montero, R | 1 |
| Alvarez-Tejerina, A | 1 |
5 other studies available for tacrine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavi | 2007 |
Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Drug Therapy, Combination; Haloperidol; Hum | 1995 |
Adverse interaction of tacrine and haloperidol.
Topics: Aged; Dementia; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Parkinson | 1996 |
Motor dysfunction produced by tacrine administration in rats.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Operant; Dose-Response Relationship, Drug; Dyskine | 1997 |
[Parkinsonian syndrome related to tacrine].
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Dementia; Humans; Male; Parkinson Disease, Secon | 1999 |